Annual Notification of Section 204/CMS RxDC Reporting Practices
Curious how we are handling reporting for 2023? Read on for more information.
On May 22, 2024, PharmAvail successfully submitted data in accordance with the Consolidated Appropriations Act, 2021 (CAA) ahead of the June 1 deadline.
PharmAvail is pleased to report that the RxDC reporting required under Section 204 of the Consolidation Appropriations Act was successfully submitted on Wednesday, May 22, 2024, ahead of the CMS deadline of June 1, 2024.
PharmAvail has worked diligently since this regulation was passed to ensure total compliance with the ever-evolving requirements related to the RxDC reporting. Even though the CMS requirements place the obligation to report on the plan sponsors, as a partner in healthcare PharmAvail felt it was in line with our company values to offer assistance in this process.
Files Submitted:
We are pleased to provide this service at no charge to our clients. At PharmAvail , we work closely with our clients to ensure their unique needs are met. Known for our high-touch service, actionable analytics, and forward-thinking management strategies, we take a collaborative approach to controlling costs without compromising care.
If you have any questions, please contact us directly at customersupport@rxipm.com.